During the past decade, Celerion conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 24 clinical trials were completed, i.e. on average, 20.3% percent of trials that started reached the finish line to date. In the past 5 years, 52 clinical trials started and 18 clinical trials were completed. i.e. 34.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Celerion" #1 sponsor was "Janssen Research & Development, LLC" with 11 trials, followed by "Takeda" with 8 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Corium, Inc." with 5 trials sponsored and "Acerta Pharma BV" with 5 trials sponsored. Other sponsors include 102 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Celerion" #1 collaborator was "Celerion" with 23 trials as a collaborator, "Loxo Oncology, Inc." with 6 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Celerion" are "Healthy" (43 trials), "Healthy Volunteers" (29 trials), "Alzheimer's Disease" (3 trials), "Gout" (3 trials) and "Hyperuricemia" (3 trials). Many other conditions were trialed in "Celerion" in a lesser frequency.

Most popular intervention types in "Celerion" are "Drug" (132 trials), "Other" (11 trials), "Biological" (4 trials), "Combination Product" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Itraconazole" (8 trials), "Omeprazole" (6 trials), "Selpercatinib" (6 trials) and "Donepezil TDS" (4 trials). Other intervention names were less common.

The vast majority of trials in "Celerion" are 133 trials for "All" genders, 6 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Celerion". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 124 completed trials in Celerion, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Celerion, 125 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".